The effects of desipramine and iprindole on levels of enantiomers of fluoxetine in rat brain and urine
- 1 January 1994
- Vol. 6 (2) , 86-90
- https://doi.org/10.1002/chir.530060208
Abstract
The antidepressant fluoxetine (FLU) and its N‐demethylated metabolite, norfluoxetine (NFLU), each contains a chiral center. The combination of FLU and desipramine (DMI), another antidepressant, has been reported to be useful in treatment of depression, to dramatically increase plasma levels of DMI and also to produce more rapid β‐adrenergic receptor down‐regulation in brain than caused by DMI alone. We have now begun studies on the effects of this drug combination on the levels of FLU and NFLU enantiomers in the rat. In addition, the combination of FLU and iprindole (IPR) was also investigated. Male Sprague–Dawley rats were treated intraperitoneally with either normal saline vehicle, DMI (5 mg/kg/day), (R,S)‐FLU (10 mg/kg/day) or DMI (5 mg/kg/day) + (R,S)‐FLU (10 mg/kg/day) for 4 days. Following the last treatment, 24 h urine samples were collected. Rats were sacrificed and brains were removed. For the IPR study, rats were pretreated with either saline or IPR‐HCl (11.2 mg/kg) and then treated 1 h later with (R,S)‐FLU. After 5 h, the rats were sacrificed and brains were removed. Brain and urine samples were analyzed by gas chromatography with electron‐capture detection for free (R)‐ and (S)‐FLU and (R)‐ and (S)‐NFLU after extraction and reaction with (−)‐(S)‐N‐(trifluoroacetyl)prolyl chloride. The results from the brains of the rats treated with DMI/FLU indicate that levels of the enantiomers of both FLU and NFLU were significantly increased over those seen in the animals receiving (R,S)‐FLU alone. In the IPR/FLU treated rats, an increase in the brain levels of both (R)‐ and (S)‐FLU was noted when compared with rats receiving (R,S)‐FLU alone; however, there appeared to be no increase in the brain levels of NFLU enantiomers.Keywords
This publication has 28 references indexed in Scilit:
- Fluoxetine impairs clearance of alprazolam but not of clonazepamClinical Pharmacology & Therapeutics, 1992
- Fluoxetine Inhibits Desipramine MetabolismArchives of General Psychiatry, 1992
- The effect of selective serotonin re‐uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.British Journal of Clinical Pharmacology, 1992
- Quantification and mechanism of the fluoxetine and tricyclic antidepressant interactionClinical Pharmacology & Therapeutics, 1992
- Fluoxetine and norfluoxetine are potent inhibitors of P450IID6‐the source of the sparteine/debrisoquine oxidation polymorphism [letter]British Journal of Clinical Pharmacology, 1991
- Increased carbamazepine plasma concentrations after fluoxetine coadministrationClinical Pharmacology & Therapeutics, 1991
- A Preliminary, Open Study of the Combination of Fluoxetine and Desipramine for Rapid Treatment of Major DepressionArchives of General Psychiatry, 1991
- Elevated antidepressant plasma levels after addition of fluoxetineAmerican Journal of Psychiatry, 1989
- Implications of chirality and geometric isomerism in some psychoactive drugs and their metabolitesChirality, 1989
- Inhibition of serotonin uptake by optical isomers of fluoxetineDrug Development Research, 1985